AVAC tracks global PrEP use by conducting quarterly surveys of ongoing oral PrEP demonstration and implementation projects, and collecting data from manufacturers and government agencies. This graphic shows data on PrEP initiations around the globe. For more trends in oral PrEP uptake, visit PrEPWatch.
The AVAC Advocacy Fellows Program is now recruiting its 13th class and is looking for the next cohort of emerging and mid-career advocates to explore what’s needed to address epidemics and progress global public health equity.
Want to help spread the word? Download our shareable social media tile.
A number of broadly neutralizing antibodies that target various regions of HIV’s Env protein are being developed for HIV prevention.
This new timeline shows the potential time points when the next-generation of HIV prevention options might find their way into new programs.
This graphic shows currently available options for HIV prevention, newly approved and recommended treatment, and those in development.